Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity
- Melody Tsai†1,
- Ryosuke L Ohniwa†1,
- Yusuke Kato2,
- Sayaka L Takeshita1,
- Toshiko Ohta1,
- Shinji Saito1,
- Hideo Hayashi3 and
- Kazuya Morikawa1Email author
© Tsai et al; licensee BioMed Central Ltd. 2011
Received: 21 June 2010
Accepted: 18 January 2011
Published: 18 January 2011
The ability of staphylococci to grow in a wide range of salt concentrations is well documented. In this study, we aimed to clarify the role of cardiolipin (CL) in the adaptation of Staphylococcus aureus to high salinity.
Using an improved extraction method, the analysis of phospholipid composition suggested that CL levels increased slightly toward stationary phase, but that this was not induced by high salinity. Deletion of the two CL synthase genes, SA1155 (cls1) and SA1891 (cls2), abolished CL synthesis. The cls2 gene encoded the dominant CL synthase. In a cls2 deletion mutant, Cls1 functioned under stress conditions, including high salinity. Using these mutants, CL was shown to be unnecessary for growth in either basal or high-salt conditions, but it was critical for prolonged survival in high-salt conditions and for generation of the L-form.
CL is not essential for S. aureus growth under conditions of high salinity, but is necessary for survival under prolonged high-salt stress and for the generation of L-form variants.
Staphylococcus aureus is an opportunistic pathogen that causes a wide range of diseases in both immunologically normal and compromised hosts. The natural habitat of S. aureus is the nasal cavity of warm-blooded animals. Over the past ~50 years, S. aureus has undergone genetic changes that have resulted in antibiotic-resistant strains [1, 2]. Importantly, the methicillin-resistant strains (MRSA) are now the most common cause of nosocomial S. aureus infections and are spreading throughout communities .
Staphylococcus aureus has a number of characteristics that allow it to survive host bactericidal factors and environmental stresses, including drastic changes in osmotic pressure [4–6]. Osmoprotectants such as choline, glycine betaine, and proline accumulate in cells in response to osmotic stress [7–11]. Multiple genes, including the branched-chain amino acid transporter gene brnQ and the arsenic operon regulatory gene arsR, cooperatively participate in salt tolerance. In addition, a very large cell wall protein, Ebh, is involved in tolerance to transient hyperosmotic pressure .
In general strategy, the phospholipid composition of bacteria changes in response to growth phase or environmental stressors such as osmolality , pH [16, 17], temperature, and the presence of organic solvents [18, 19]. In the 1970s, the molecular mechanism of staphylococcal salt resistance was studied, focusing on a phospholipid, cardiolipin (CL) . CL possesses four acyl groups and carries two negative charges . In stationary phase, 30% of the S. aureus cell membrane is composed of CL . It has been reported that CL can stabilize liposomes during osmotic stress  and that it is required for the growth of Escherichia coli and Bacillus subtilis under high-salt conditions [24, 25]. However, the role of CL in the molecular mechanism of staphylococcal resistance to high salinity remains unknown.
In this study, we used an improved lipid extraction method to assess the phospholipid composition of S. aureus and performed molecular genetic analyses to evaluate the role of CL in the resistance of S. aureus to high salinity.
Staphylococcus aureus phospholipid composition
Molecular genetic analysis of two cardiolipin synthase homologs
Importance of CL for long-term survival under high salinity
No difference in susceptibility to antibiotics affecting cell walls (vancomycin, teicoplanin, cefarotin, cefmetazole, and cefazoline), quinolones (ofloxacin, norfloxacin, ciprofloxacin, and nalidixic acid), arbekacin, or the antimicrobial peptides ASABF-α  and nisin was observed between the N315 and its cls mutants (data not shown). The MIC of nisin for both S. aureus N315 and its cls mutants was 80 μg ml-1.
Effect of cls mutations on L-form generation
Function of cls1 in stress responses
Cardiolipin is known to play a role in the adaptive mechanisms of some bacteria to high salinity stress [15, 20, 37]. For example, a deficiency in CL decreases the growth rate in B. subtilis under conditions of 1.5 M (8.76%) NaCl . Additionally, salt-sensitive S. aureus mutants contain no or only a small amount of CL [38, 39]. Therefore, we were surprised to find that the growth of S. aureus under conditions of high salinity did not depend on CL (Figure 6). This may be attributable to the presence of other mechanisms, including species-specific systems such as variations in cell wall proteins , that give staphylococci the ability to cope with high-salt stress [11, 40]. However, this study is, to our knowledge, the first to demonstrate that CL is important for long-term fitness of S. aureus under conditions of high salinity. This is an important finding in understanding the NaCl resistance of S. aureus, which is itself important for commensal growth on skin and mucus membranes, survival on dry surfaces during indirect transmission, and persistence in foods with a high salt content .
Cardiolipin depletion did not increase the susceptibility of S. aureus to cell wall-targeted antibiotics, suggesting that CL alone is not responsible for bacterial survival against these challenges. We also examined the susceptibility of S. aureus and its cls mutants to cationic antimicrobial peptides; because cardiolipin is negatively charged, a decrease in total negative charge on the membrane surface may contribute to reduced cationic antimicrobial peptide resistance . However, CL depletion had no effect on susceptibility to the antimicrobial peptides ASABF-α and nisin. It is possible that the net negative charge is compensated for by other membrane components such as PG. In fact, the PG level was increased in the mutants that did not accumulate CL. The importance of positively charged lysyl-phosphatidylglycerol (LPG) (or MprF protein) in resistance to cationic antimicrobial peptides has been reported [43, 44], and the LPG level was not different between wild-type S. aureus and cls mutants. In addition to the probable effect of cell surface charge, we have previously reported that cell wall thickness is an important factor affecting resistance to the antimicrobial peptide ASABF-α . Furthermore, in the present study, ASABF-α-resistant strains had cell walls that interfered with CL extraction (Additional file 1, Figure S1). Cell wall thickness may also be related to resistance against other antimicrobial peptides in S. aureus[45, 46].
Our data indicate that lysostaphin treatment is critical for the efficient extraction of CL from S. aureus. Previous reports have suggested that CL is not readily extractable from B. subtilis and other Gram-positive bacteria without lysozyme treatment . This may be attributable to its large molecular mass (~1500 Da) relative to that of other phospholipids, owing to its four acyl residues. However, ~25-kDa globular hydrophilic molecules can pass freely through the ~2-nm holes in the peptidoglycan polymer that forms the cell wall of Gram-positive bacteria . Instead, the efficiency of CL extraction is likely reduced by its physical interactions with cell wall components; for example, when CL is bound to cell wall components, it will not efficiently enter the organic phase during extraction.
The membrane of the L-form variants of S. aureus is thought to express certain features that support cell growth and survival in the absence of a rigid cell wall. One study reported that a particular L-form strain had an increased CL level . Our data demonstrate that the cls2 gene is important for normal L-form generation. However, the cls1/cls2 double mutant still produced L-form cells, suggesting the existence of a CL-independent mechanism. Thus, multiple mechanisms may function in cooperation to generate L-form variants. The production of a number of factors such as carotenoids, catalase, coagulase, lipase, fibrinolysin, hemolysin, and enterotoxin changes upon L-form generation and reversion [49–52]. However, none of these represents a common L-form variant phenotype, suggesting that L-form generation is associated with a drastic phenotypic conversion. The increase in CL content may be important, but not essential, for membrane stabilization.
In this study, both cls1 and cls2 were shown to encode functional CL synthases. Under our experimental conditions, cls2 was the dominant CL synthase gene. The cls1 mutant did not differ from the parental strain in its growth rate, survival at stationary phase, total CL accumulation, or L-form generation. However, our data indicate that the synthesis of CL by Cls1 helps the cls2 mutant to survive prolonged incubation under high-salt conditions (Figure 5E), suggesting that Cls1 has a specific function under stress conditions if Cls2 is unavailable. Future studies should examine the functional characteristics of these two CL synthases, including possible differences in their subcellular localizations.
Improved lipid extraction and molecular genetic analyses showed that both cls1 and cls2 participate in CL accumulation. The cls2 gene appears to serve a housekeeping function, while cls1 is active under stress conditions. Staphylococcus aureus can grow under conditions of high salinity without CL, but CL is required to survive prolonged high salinity stress and to generate L-form variants. This CL-dependent survival helps to explain the success of S. aureus as a human pathogen and skin/mucus membrane commensal.
Bacterial strains and culture conditions
Bacterial strains, plasmids, and primers used in this study
Strain or plasmid
S. aureus strain
8325-4 derivative that accept foreign DNA
RN4220 ΔSA1155; Cmr
RN4220 ΔSA1891; Tetr
RN4220 ΔSA1155/ ΔSA1891; Cmr Tetr
pre-methicillin resistant strain
N315 ΔSA1155; Cmr
N315 ΔSA1891; Tetr
N315 ΔSA1155/ ΔSA1891; Cmr Tetr
NCTC 8325 cured of prophages, rsbU(-)
8325-4 ΔSA1155; Cmr
8325-4 ΔSA1891; Tetr
8325-4 ΔSA1155/ ΔSA1891; Cmr Tetr
8325-4 derivative, rsbU repaired, rsbU(+)
SH1000 ΔSA1155; Cmr
SH1000 ΔSA1891; Tetr
SH1000 ΔSA1155/ ΔSA1891; Cmr Tetr
isolate from healthy host, able to generate L-form
MT01 ΔSA1155; Cmr
MT01 ΔSA1891; Tetr
MT01 ΔSA1155/ ΔSA1891; Cmr Tetr
thermosensitive, pE194ts-based delivery vector
pMAD-based SA1155 targeting vector
pMAD-based SA1891 targeting vector
shuttle vector, tet (TetR)
shuttle vector, cm(CmR)
Lipid extraction and thin-layer chromatography
Cells equivalent to 8 × 108 CFU were collected at exponential or stationary phase, washed in 2% NaCl, and resuspended in 200 μl of 2% NaCl. Lysostaphin (0.1 mg ml-1) was added, and the mixture was incubated at 37°C for 3 min. The lysed cell suspension was extracted with chloroform-methanol. Briefly, a five-fold volume of chloroform-methanol (2:1; v/v) was added, mixed vigorously for 2 min, and left at room temperature for 10 min. Following the addition of a three-fold volume of chloroform-2% NaCl (1:1; v/v) and centrifugation, the lower layer was recovered and concentrated under vacuum. The lipids were dissolved in chloroform-methanol (2:1; v/v), applied to silica thin-layer chromatography (TLC) plates (Silica gel 60; Merck, Darmstadt, Germany), and developed with chloroform-methanol-acetic acid (65:25:10; v/v/v). The TLC plates were sprayed with CuSO4 (100 mg ml-1) containing 8% phosphoric acid and heated at 180°C to visualize the phospholipids. A digital image was obtained using a scanner, and signal intensities were quantified by ImageJ software (version 1.43U, NIH).
Construction of mutants
To construct S. aureus mutants, we used pMAD, which is designed for efficient allelic replacement in Gram-positive bacteria , and incorporated the tetracycline or chloramphenicol resistance gene to make it suitable for use with erythromycin-resistant hosts such as S. aureus N315. The tet gene was amplified with primers Tet-F(Sal) and Tet-R(EcoRI) using pHY300PLK (Takara Shuzo Co. Ltd., Kyoto, Japan) as a template and ligated into the Eco RI-Sal I site of pMAD to generate pMADtet. The cat gene was amplified from pRIT5H  with primers CAT(Sal)F and CAT(Eco)R and ligated into the Eco RI-Sal I site of pMAD to generate pMADcat.
Target vectors were designed to replace the SA1155 (cls1) and SA1891 (cls2) genes with cat and tet, respectively. Two regions encompassing SA1155 were amplified with the primer pairs clsU1p and clsU2p (upstream region) and clsD1p and clsD2p (downstream region), restricted at the primer-attached sites, and sequentially ligated into the Bam HI-Sal I and Bgl II sites of pMADcat to generate the target plasmid pMADcat1155. Similarly, the upstream and downstream regions of SA1891 were amplified with the primer pairs 1891U1 and 1891U2, and 1891D1 and 1891D2, and then sequentially ligated into the Bam HI-Sal I and Eco RI-Bgl II sites of pMADtet to generate pMADtet1891. These target vectors were introduced into S. aureus RN4220 and N315 by electroporation. Each mutant was isolated as described previously . Briefly, β-galactosidase-positive colonies carrying the target vector were plated on TSB agar (TSA) containing antibiotic (12.5 μg ml-1 Cm or 5 μg ml-1 Tet) and 100 μg ml-1 X-gal, followed by incubation at 42°C overnight. Several resulting blue colonies were pooled and subjected to three cycles of growth in drug-free TSB at 30°C for 12 h and at 42°C for 12 h. Dilutions were plated on drug-free TSA plates containing 100 μg ml-1 X-gal. Homologous recombination in white colonies was detected by PCR and Southern blot analyses. The SA1155/SA1891 double mutants of RN4220 and N315, the SA1155 and SA1891 single mutants, and the SA1155/SA1891 double mutants of SH1000, 8325-4, and MT01 were obtained by phage transduction. The absence of the genes in each mutant was confirmed by Southern blot analysis and/or PCR.
Antibiotic and antimicrobial peptide susceptibility test
Cells were grown overnight in 5 ml of drug-free Muller-Hinton (MH) broth at 37°C with shaking (180 rpm; BR-1; TAITEC). These cells were diluted with MH (×10-4) and plated onto MH agar. Antibiotic susceptibilities of the strains were compared using the disk diffusion method (BD BBL sensi-Disk; Becton, Dickinson and Co., Franklin Lakes, NJ). The susceptibilities to ASABF-α were measured as described previously . The minimum inhibitory concentration (MIC) of nisin (from Lactococcus lactis; Sigma, St. Louis, MO) was determined by microdilution with 104 cells per well and a 20-h incubation at 37°C.
Cells were cultured in BHI without antibiotics, and 100 μl of the overnight culture were spread onto BHI agar plates containing 5% NaCl, 5% sucrose, 10% heat-inactivated horse serum, and 100 μg ml-1 penicillin. The presence of serum selects for the stable L-form of S. aureus. The plates were incubated at 37°C, and colonies showing the L-form ('fried egg shape') were counted for 8 days post-inoculation .
We thank Dr. Michel Débarbouillé (Institut Pasteur, CNRS) for providing the pMAD vector.
This study was supported by The Sasakawa Scientific Research Grant from The Japan Science Society 21-421 to MT, JSPS Grant-in-Aid for Scientific Research (C) 17590405 to HH, The Ichiro Kanehara Foundation 09KI202 to KM, and The Salt Science Research Foundation 0826 to KM.
- Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K: Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat. 2003, 6 (1): 41-52. 10.1016/S1368-7646(03)00003-7.PubMedView Article
- McCallum N, Berger-Bachi B, Senn MM: Regulation of antibiotic resistance in Staphylococcus aureus. Int J Med Microbiol. 2009, 300 (2-3): 118-129. 10.1016/j.ijmm.2009.08.015.PubMedView Article
- Chambers HF, Deleo FR: Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009, 7 (9): 629-641. 10.1038/nrmicro2200.PubMedPubMed CentralView Article
- Clements MO, Foster SJ: Stress resistance in Staphylococcus aureus. Trends Microbiol. 1999, 7 (11): 458-462. 10.1016/S0966-842X(99)01607-8.PubMedView Article
- Garzoni C, Kelley WL: Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol. 2009, 17 (2): 59-65. 10.1016/j.tim.2008.11.005.PubMedView Article
- Morikawa K, Ohniwa RL, Ohta T, Tanaka Y, Takeyasu K, Msadek T: Adaptation beyond the Stress Response: Cell Structure Dynamics and Population Heterogeneity in Staphylococcus aureus. Microbs Environ. 2010, 25 (2): 75-82. 10.1264/jsme2.ME10116.View Article
- Amin US, Lash TD, Wilkinson BJ: Proline betaine is a highly effective osmoprotectant for Staphylococcus aureus. Arch Microbiol. 1995, 163 (2): 138-142. 10.1007/BF00381788.PubMedView Article
- Graham JE, Wilkinson BJ: Staphylococcus aureus osmoregulation: roles for choline, glycine betaine, proline, and taurine. JBacteriol. 1992, 174 (8): 2711-2716.
- Miller KJ, Zelt SC, Bae J: Glycine betaine and proline are the principal compatible solutes of Staphylococcus aureus. Current Microbiology. 1991, 23: 131-137. 10.1007/BF02091971.View Article
- Peddie BA, Lever M, Randall K, Chambers ST: Osmoprotective activity, urea protection, and accumulation of hydrophilic betaines in Escherichia coli and Staphylococcus aureus. Antonie Van Leeuwenhoek. 1999, 75 (3): 183-189. 10.1023/A:1001701400801.PubMedView Article
- Wilkinson BJ: Biology. The staphylococci in human disease. Edited by: Crossley KB, Archer GL. 1996, Churchill Livingstone, 1-38.
- Vijaranakul U, Xiong A, Lockwood K, Jayaswal RK: Cloning and nucleotide sequencing of a Staphylococcus aureus gene encoding a branched-chain-amino-acid transporter. Appl Environ Microbiol. 1998, 64 (2): 763-767.PubMedPubMed Central
- Scybert S, Pechous R, Sitthisak S, Nadakavukaren MJ, Wilkinson BJ, Jayaswal RK: NaCl-sensitive mutant of Staphylococcus aureus has a Tn917-lacZ insertion in its ars operon. FEMS Microbiol Lett. 2003, 222 (2): 171-176. 10.1016/S0378-1097(03)00312-4.PubMedView Article
- Kuroda M, Tanaka Y, Aoki R, Shu D, Tsumoto K, Ohta T: Staphylococcus aureus giant protein Ebh is involved in tolerance to transient hyperosmotic pressure. Biochem Biophys Res Commun. 2008, 374 (2): 237-241. 10.1016/j.bbrc.2008.07.037.PubMedView Article
- Romantsov T, Guan Z, Wood JM: Cardiolipin and the osmotic stress responses of bacteria. Biochim Biophys Acta. 2009, 1788 (10): 2092-2100. 10.1016/j.bbamem.2009.06.010.PubMedPubMed CentralView Article
- Gould RM, Lennarz WJ: Metabolism of Phosphatidylglycerol and Lysyl Phosphatidylglycerol in Staphylococcus aureus. JBacteriol. 1970, 104 (3): 1135-1144.
- Minnikin DE, Abdolrahimzadeh H: Effect of pH on the proportions of polar lipids, in chemostat cultures of Bacillus subtilis. JBacteriol. 1974, 120 (3): 999-1003.
- Bernal P, Segura A, Ramos JL: Compensatory role of the cis-trans-isomerase and cardiolipin synthase in the membrane fluidity of Pseudomonas putida DOT-T1E. Environ Microbiol. 2007, 9 (7): 1658-1664. 10.1111/j.1462-2920.2007.01283.x.PubMedView Article
- Ramos JL, Duque E, Gallegos MT, Godoy P, Ramos-Gonzalez MI, Rojas A, Teran W, Segura A: Mechanisms of solvent tolerance in gram-negative bacteria. Annu Rev Microbiol. 2002, 56: 743-768. 10.1146/annurev.micro.56.012302.161038.PubMedView Article
- Kanemasa Y, Yoshioka T, Hayashi H: Alteration of the phospholipid composition of Staphylococcus aureus cultured in medium containing NaCl. Biochim Biophys Acta. 1972, 280 (3): 444-450.PubMedView Article
- Schlame M: Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res. 2008, 49 (8): 1607-1620. 10.1194/jlr.R700018-JLR200.PubMedPubMed CentralView Article
- Short SA, White DC: Metabolism of phosphatidylglycerol, lysylphosphatidylglycerol, and cardiolipin of Staphylococcus aureus. JBacteriol. 1971, 108 (1): 219-226.
- Nagamachi E, Hirai Y, Tomochika K, Kanemasa Y: Studies on osmotic stability of liposomes prepared with bacterial membrane lipids by carboxyfluorescein release. Microbiol Immunol. 1992, 36 (3): 231-234.PubMedView Article
- Lopez CS, Alice AF, Heras H, Rivas EA, Sanchez-Rivas C: Role of anionic phospholipids in the adaptation of Bacillus subtilis to high salinity. Microbiology. 2006, 152 (Pt 3): 605-616. 10.1099/mic.0.28345-0.PubMedView Article
- Romantsov T, Helbig S, Culham DE, Gill C, Stalker L, Wood JM: Cardiolipin promotes polar localization of osmosensory transporter ProP in Escherichia coli. Mol Microbiol. 2007, 64 (6): 1455-1465. 10.1111/j.1365-2958.2007.05727.x.PubMedView Article
- Schindler CA, Schuhardt VT: Lysostaphin: A New Bacteriolytic Agent for the Staphylococcus. Proc Natl Acad Sci USA. 1964, 51: 414-421. 10.1073/pnas.51.3.414.PubMedPubMed CentralView Article
- Iversen OJ, Grov A: Studies on lysostaphin. Separation and characterization of three enzymes. Eur J Biochem. 1973, 38 (2): 293-300. 10.1111/j.1432-1033.1973.tb03061.x.PubMedView Article
- Ichihashi N, Kurokawa K, Matsuo M, Kaito C, Sekimizu K: Inhibitory effects of basic or neutral phospholipid on acidic phospholipid-mediated dissociation of adenine nucleotide bound to DnaA protein, the initiator of chromosomal DNA replication. J Biol Chem. 2003, 278 (31): 28778-18786. 10.1074/jbc.M212202200.PubMedView Article
- Salzberg LI, Helmann JD: Phenotypic and transcriptomic characterization of Bacillus subtilis mutants with grossly altered membrane composition. JBacteriol. 2008, 190 (23): 7797-7807. 10.1128/JB.00720-08.View Article
- Kawai F, Shoda M, Harashima R, Sadaie Y, Hara H, Matsumoto K: Cardiolipin domains in Bacillus subtilis marburg membranes. JBacteriol. 2004, 186 (5): 1475-1483. 10.1128/JB.186.5.1475-1483.2004.View Article
- Sekimizu K, Kornberg A: Cardiolipin activation of dnaA protein, the initiation protein of replication in Escherichia coli. J Biol Chem. 1988, 263 (15): 7131-7135.PubMed
- Mileykovskaya E, Dowhan W: Cardiolipin membrane domains in prokaryotes and eukaryotes. Biochim Biophys Acta. 2009, 1788 (10): 2084-2091. 10.1016/j.bbamem.2009.04.003.PubMedPubMed CentralView Article
- Zhang H, Morikawa K, Ohta T, Kato Y: In vitro resistance to the CSαβ-type antimicrobial peptide ASABF-α is conferred by overexpression of sigma factor sigB in Staphylococcus aureus. J Antimicrob Chemother. 2005, 55 (5): 686-691. 10.1093/jac/dki070.PubMedView Article
- Shimokawa O, Ikeda M, Umeda A, Nakayama H: Serum inhibits penicillin-induced L-form growth in Staphylococcus aureus: a note of caution on the use of serum in cultivation of bacterial L-forms. JBacteriol. 1994, 176 (9): 2751-2753.
- Allan EJ, Hoischen C, Gumpert J: Bacterial L-forms. Adv Appl Microbiol. 2009, 68: 1-39. full_text.PubMedView Article
- Hayami M, Okabe A, Kariyama R, Abe M, Kanemasa Y: Lipid composition of Staphylococcus aureus and its derived L-forms. Microbiol Immunol. 1979, 23 (6): 435-442.PubMedView Article
- De Leo V, Catucci L, Ventrella A, Milano F, Agostiano A, Corcelli A: Cardiolipin increases in chromatophores isolated from Rhodobacter sphaeroides after osmotic stress: structural and functional roles. J Lipid Res. 2009, 50 (2): 256-264. 10.1194/jlr.M800312-JLR200.PubMedView Article
- Kanemasa Y, Takatsu T, Sasai K, Kojima I, Hayashi H: The salt-resistance mechanism of Staphylococcus aureus examined by salt-sensitive mutants. Acta Med Okayama. 1976, 30 (4): 271-276.PubMed
- Kanemasa Y, Katayama T, Hayashi H, Takatsu T, Tomochika K, Okabe A: The barrier role of cytoplasmic membrane in salt tolerance mechanism in Staphylococcus aureus. Staphylocci and staphylococcal diseases. Edited by: Jeljaszewicz J Stuttgart. 1976, New York: Fischer, 189-201.
- Kanemasa Y, Takai K, Takatsu T, Hayashi H, Katayama T: Ultrastructural alteration of the cell surface of Staphylococcus aureus cultured in a different salt condition. Acta Med Okayama. 1974, 28 (5): 311-320.PubMed
- Wijnker JJ, Koop G, Lipman LJ: Antimicrobial properties of salt (NaCl) used for the preservation of natural casings. Food Microbiol. 2006, 23 (7): 657-662. 10.1016/j.fm.2005.11.004.PubMedView Article
- Mukhopadhyay K, Whitmire W, Xiong YQ, Molden J, Jones T, Peschel A, Staubitz P, Adler-Moore J, McNamara PJ, Proctor RA: In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. Microbiology. 2007, 153 (Pt 4): 1187-1197. 10.1099/mic.0. 2006/003111-0.PubMedView Article
- Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A: Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J Exp Med. 2001, 193 (9): 1067-1076. 10.1084/jem.193.9.1067.PubMedPubMed CentralView Article
- Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A: The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog. 2009, 5 (11): e1000660-10.1371/journal.ppat.1000660.PubMedPubMed CentralView Article
- Mishra NN, Yang SJ, Sawa A, Rubio A, Nast CC, Yeaman MR, Bayer AS: Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009, 53 (6): 2312-2318. 10.1128/AAC.01682-08.PubMedPubMed CentralView Article
- Dorschner RA, Lopez-Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V, Gallo RL: The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. Faseb J. 2006, 20 (1): 35-42. 10.1096/fj.05-4406com.PubMedView Article
- Filgueiras MH, Op den Kamp JA: Cardiolipin, a major phospholipid of Gram-positive bacteria that is not readily extractable. Biochim Biophys Acta. 1980, 620 (2): 332-337.PubMedView Article
- Demchick P, Koch AL: The permeability of the wall fabric of Escherichia coli and Bacillus subtilis. JBacteriol. 1996, 178 (3): 768-773.
- Czop JK, Bergdoll MS: Synthesis of Enterotoxin by L-Forms of Staphylococcus aureus. Infect Immun. 1970, 1 (2): 169-173.PubMedPubMed Central
- Rosdahl VT, Vejlsgaard R: Investigation of the penicillinase activity in L colonies of Staphylococcus aureus. Appl Microbiol. 1970, 20 (6): 871-874.PubMedPubMed Central
- Smith JA, Willis AT: Some physiological characters of L forms of Staphylococcus aureus. J Pathol Bacteriol. 1967, 94 (2): 359-365. 10.1002/path.1700940215.PubMedView Article
- Sato H, Ohya T: Studies on biological characteristics of staphylococcal L-forms. Bulletin of the Faculty of Agriculture, Kagoshima University. 1987, 37: 167-174.
- Arnaud M, Chastanet A, Debarbouille M: New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol. 2004, 70 (11): 6887-6891. 10.1128/AEM.70.11.6887-6891.2004.PubMedPubMed CentralView Article
- Inose Y, Takeshita SL, Hidaka T, Higashide M, Maruyama A, Hayashi H, Morikawa K, Ohta T: Genetic characterization of the natural SigB variants found in clinical isolates of Staphylococcus aureus. J Gen Appl Microbiol. 2006, 52 (5): 259-271. 10.2323/jgam.52.259.PubMedView Article
- Kreiswirth BN, Lofdahl S, Betley MJ, O'Reilly M, Schlievert PM, Bergdoll MS, Novick RP: The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature. 1983, 305 (5936): 709-712. 10.1038/305709a0.PubMedView Article
- Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y: Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet. 2001, 357 (9264): 1225-1240. 10.1016/S0140-6736(00)04403-2.PubMedView Article
- Novick R: Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology. 1967, 33 (1): 155-166. 10.1016/0042-6822(67)90105-5.PubMedView Article
- Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ: σB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. JBacteriol. 2002, 184 (19): 5457-5467. 10.1128/JB.184.19.5457-5467.2002.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.